What top creators are saying about Intuitive Surgical Inc.(ISRG)

Mentioned as part of market rotation into healthcare, without detailed company-specific investment analysis.

Cited as a leading healthcare-robotics company and an example of robotics' established presence in healthcare; the discussion provides no specific stock forecast.

Intuitive was mentioned as an earnings-calendar item, without an earnings estimate or investment recommendation.

The quarter showed business growth and operating leverage, with recurring services, upgrades, and platform stickiness supporting the business; the speaker liked the company but had not yet bought the stock.

Intuitive Surgical was mentioned in an earnings-calendar discussion without stock-specific investment analysis.

Mentioned only as an upcoming earnings report; no company-specific forecast or recommendation was provided.

The guest saw potential benefits from AI-enabled surgical robotics but acknowledged that the stock was expensive.

Undergoing a severe technical downtrend from $600 toward $350; watch upcoming earnings for a potential relief rally toward $460.

Avoid or potential short; management criticized for missing BCI opportunities and valuation remains expensive despite a 10% drop.

Mentioned as a relevant asset in the investment context.

Dominant market position with high growth potential; current technical dip to low $400s is seen as a strong entry point for long-term compounding.

Safer medical play with strong growth; identified as a buy at the $417 support level.

Highlighted as a stock showing strength and leadership within the healthcare sector, which is seen as a laggard where a 'turn is the real deal'.

Mentioned with bullish sentiment in passing as a 'real company' with a strong business model, contrasting it with speculative stocks.

Removed from the GRNY ETF portfolio during its August 2025 rebalance.